Sei Investments CO Global Blood Therapeutics, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $639,681 - $1.03 Million	-25,690 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $352,770 - $516,972	-13,845 Reduced 35.02%	25,690 $650,000
Q2 2021 Aug 06, 2021	BUY	$32.46 - $43.42 $361,247 - $483,221	11,129 Added 39.18%	39,535 $1.38 Million
Q1 2021 May 12, 2021	BUY	$38.94 - $50.85 $14,290 - $18,661	367 Added 1.31%	28,406 $1.16 Million
Q4 2020 Feb 08, 2021	SELL	$37.65 - $63.77 $929,540 - $1.57 Million	-24,689 Reduced 46.82%	28,039 $1.22 Million
Q3 2020 Nov 06, 2020	SELL	$52.76 - $74.49 $1.04 Million - $1.47 Million	-19,751 Reduced 27.25%	52,728 $2.91 Million
Q2 2020 Aug 17, 2020	BUY	$48.73 - $81.82 $2.63 Million - $4.42 Million	54,020 Added 292.65%	72,479 $4.58 Million
Q2 2020 Aug 11, 2020	SELL	$48.73 - $81.82 $1.91 Million - $3.2 Million	-39,146 Reduced 67.96%	18,459 $1.47 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $1.16 Million - $2.42 Million	27,778 Added 93.13%	57,605 $2.94 Million
Q4 2019 Feb 06, 2020	BUY	$45.7 - $81.86 $1.36 Million - $2.44 Million	29,827 New	29,827 $2.37 Million
Q3 2019 Nov 12, 2019	SELL	$45.35 - $57.91 $1.08 Million - $1.38 Million	-23,751 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $1.07 Million - $1.28 Million	20,291 Added 586.45%	23,751 $1.28 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $158,760 - $212,315	-3,970 Reduced 53.43%	3,460 $183,000
Q3 2018 Nov 08, 2018	SELL	$38.0 - $51.1 $243,960 - $328,062	-6,420 Reduced 46.35%	7,430 $282,000
Q2 2018 Aug 03, 2018	BUY	$38.7 - $50.15 $58,011 - $75,174	1,499 Added 12.14%	13,850 $626,000
Q1 2018 May 11, 2018	BUY	$39.6 - $65.9 $489,099 - $813,930	12,351 New	12,351 $597,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account